Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free

20 product images

• 

  Image from Khanom R. et al PLoS One. 2016 Aug 11;11(8):e0161163. doi: 10.1371/journal.pone.0161163. eCollection 2016.

  Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Colocalization of KRT5, KRT6 and KRT17 in HSC3 cells

  Immunocytochemistry in HSC3 (human oral squamous carcinoma cell line) cells. Scale bar, 10 μm.

  (Taken from Figure S3 of Khanom et al)

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Clone EP1601Y (ab214586) has been successfully conjugated by Abcam. This image was generated using Anti-Cytokeratin 5 antibody [EP1601Y] (Alexa Fluor® 647). Please refer to Alexa Fluor® 647 Anti-Cytokeratin 5 antibody [EP1601Y] ab193895 for protocol details.

  Alexa Fluor® 647 Anti-Cytokeratin 5 antibody [EP1601Y] ab193895 staining Cytokeratin 5 in A431 cells. The cells were fixed with 4% formaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with Alexa Fluor® 647 Anti-Cytokeratin 5 antibody [EP1601Y] ab193895 at 1/100 dilution (shown in red) and Alexa Fluor® 488 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195887, Mouse monoclonal to alpha Tubulin (Alexa Fluor^® 488), at 1/250 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

  This product also gave a positive signal under the same testing conditions in A431 cells fixed with 100% methanol (5min).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat skin tissue sections labeling Cytokeratin 5 with Purified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1:200 dilution. Heat mediated antigen retrieval was performed using Antigen Retrieval Buffer (100X Tris-EDTA Buffer, pH 9.0) ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Western blot - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  This data was developed using Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635, the same antibody clone in a different buffer formulation. Different batches of Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 were tested on Rat skin lysate at 1.0 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 62 kDa.

  All lanes: Western blot - Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635)

  Predicted band size: 62 kDa

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Clone EP1601Y (ab214586) has been successfully conjugated by Abcam. This image was generated using Anti-Cytokeratin 5 antibody [EP1601Y] (Alexa Fluor® 488). Please refer to Alexa Fluor® 488 Anti-Cytokeratin 5 antibody [EP1601Y] ab193894 for protocol details.

  Alexa Fluor® 488 Anti-Cytokeratin 5 antibody [EP1601Y] ab193894 staining Cytokeratin 5 in HACAT cells. The cells were fixed with 4% formaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 10% normal goat serum in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with Alexa Fluor® 488 Anti-Cytokeratin 5 antibody [EP1601Y] ab193894 at 1/200 dilution (shown in green) and Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889, Mouse monoclonal to alpha Tubulin (Alexa Fluor^® 594), at 1/200 dilution (shown in red). Nuclear DNA was labelled with DAPI (shown in blue).
  Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

• 

  Flow Cytometry (Intracellular) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Clone EP1601Y (ab214586) has been successfully conjugated by Abcam. This image was generated using Anti-Cytokeratin 5 antibody [EP1601Y] (PE). Please refer to PE Anti-Cytokeratin 5 antibody [EP1601Y] ab224985 for protocol details.
  

  Overlay histogram showing A431 cells stained with PE Anti-Cytokeratin 5 antibody [EP1601Y] ab224985 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (PE Anti-Cytokeratin 5 antibody [EP1601Y] ab224985, 1/5000 dilution) for 30 min at 22°C.

  Isotype control antibody (black line) was Rabbit IgG (monoclonal) Phycoerythrin (PE Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab209478) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.

  Acquisition of >5,000 events were collected using a 50 mW Yellow/Green laser (561nm) and 586/15 bandpass filter.

  This antibody gave a positive signal in A431 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Triton X-100 for 15 min used under the same conditions.

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Immunocytochemistry/ Immunofluorescence analysis of A431 (Human epidermoid carcinoma epithelial cell) cells labeling Cytokeratin 6 with Purified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1:100 dilution. Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor ® 594) 1:200 (2.5 µg/ml). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat anti rabbit IgG(Alexa Fluor ® 488) was used as the secondary antibody at 1:1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse skin tissue sections labeling Cytokeratin 5 with Purified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1:200 dilution. Heat mediated antigen retrieval was performed using Antigen Retrieval Buffer (100X Tris-EDTA Buffer, pH 9.0) ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical carcinoma tissue sections labeling Cytokeratin 5 with Purified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1:200 dilution. Heat mediated antigen retrieval was performed using Antigen Retrieval Buffer (100X Tris-EDTA Buffer, pH 9.0) ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Flow Cytometry (Intracellular) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Intracellular Flow Cytometry analysis of A431 (human epidermoid carcinoma) cells labelling Cytokeratin 5 with purified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1/20 (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. An Alexa Fluor^®488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Human transitional urinary bladder carcinoma stained with unpurified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1/100 - 1/250 dilution.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  A431 cells stained with unpurified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 at 1/100 - 1/250

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Unpurified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 showing negative staining in ductal breast carcinoma tissue.
  
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Unpurified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 showing negative staining in stomach adenocarcinoma tissue.
  
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Unpurified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 showing positive staining in normal tonsil squamous cells tissue.
  
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Unpurified Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 showing positive staining in squamous cell lung carcinoma tissue.
  
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  This IHC data was generated using the same anti-Cytokeratin 5 antibody clone, EP1601Y, in a different buffer formulation (cat# Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).
  

  Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 showing positive staining in squamous cell cervical carcinoma tissue.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  This IHC data was generated using the same anti-Cytokeratin 5 antibody clone, EP1601Y, in a different buffer formulation (cat# Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).
  

  Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635 showing positive staining in basal cell breast carcinoma tissue.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635).
  
  IHC image of Cytokeratin 5 staining in a section of formalin-fixed paraffin-embedded normal human skin* performed on a Leica Biosystems BOND® RX instrument. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635, 0.1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
  For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
  *Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre

• 

  Western blot - Anti-Cytokeratin 5 antibody [EP1601Y] - BSA and Azide free (ab214586)

  Blocking buffer: 5% NFDM /TBST.

  All lanes: Western blot - Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker (Anti-Cytokeratin 5 antibody [EP1601Y] - Cytoskeleton Marker ab52635) at 1/1000 dilution

  Lane 1: N-GST tagged full-length recombinant human Cytokeratin 6A protein at 10 ng

  Lane 2: N-GST tagged full-length recombinant human Cytokeratin 5 protein at 10 ng

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution

  Observed band size: 87 kDa

  Exposure time: 10s